Skip to content

Moxibustion to Treat Primary Dysmenorrhea with two Intervention Times: a Randomized Controlled Trial

Moxibustion to Treat Primary Dysmenorrhea with two Intervention Times: a Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14004627
Enrollment
Unknown
Registered
2014-05-19
Start date
2014-05-26
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea

Interventions

Treatment group A (treated before the menstruation:moxibustion
Treatment group B (treated within the menstruation:moxibustion
Control group C (waiting-list group):moxibustion

Sponsors

Acupuncture and Tuina School, Chengdu University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 18 to 30 years old without any history of delivery;2. Menstrual cycle was 28 ± 7 days during last 3 months;3. The diagnostic criteria of primary dysmenorrhea in the Primary Dysmenorrhea Consensus Guideline[20];4. Complied with the syndrome of stagnation of qi and blood or the syndrome of obstruction due to cold-dampness;5. Menstrual pain scored more than 40 mm on a 100 mm Visual Analogue Scale (VAS);6. Keep a dysmenorrhea diary during the baseline menstrual period;7. Agree to sign informed consent form.

Exclusion criteria

Exclusion criteria: 1. With secondary dysmenorrheal caused by endometriosis, uterine myoma, endometrial polyps, pelvic inflammatory disease, and other gynecological problems; 2. With Serious comorbid conditions (for example, life-threatening condition or progressive central disorder); 3. Any other condition likely in the judgment of the investigator that make the patient unable to complete, or is unsuitable for the study; 4. with uncontrolled diagnosed psychiatric disorders; 5. A woman who is planning to have a baby; 6. Taking anti-depressant, anti-serotonin, barbiturate, or psychotropic drugs in past 2 weeks; 7. Receiving or received any other treatment of primary dysmenorrhea in past 3 month.

Design outcomes

Primary

MeasureTime frame
PGE2/PGF2;

Countries

China

Contacts

Public ContactJie Yang
jenny_yang_jie@126.com+86 13882296714

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 18, 2026